Table 1.
Human leukocyte antigen class I-restricted cytotoxic T-lymphocyte Epstein-Barr virus epitopes
| Human leukocyte antigen | Protein | Epitope position | Epitope sequence |
| A2 | EBNA3A | 596 to 604 | SVRDRLARL |
| A2.01 | EBNA3C | 284 to 293 | LLDFVRFMGV |
| A2.01 | LMP2 | 329 to 337 | LLWTLVVLL |
| A2.01 | LMP2 | 426 to 434 | CLGGLLTMV |
| A2.01 | BMLF1 | 280 to 288 | GLCTLVAML |
| A2.06 | LMP2 | 453 to 461 | LTAGFLIFL |
| A3 | EBNA3A | 603 to 611 | RLRAEAQVK |
| A11 | EBNA3B | 399 to 408 | AVFDRKSDAK |
| A11 | EBNA3B | 416 to 424 | IVTDVSVIK |
| A11 | LMP2 | 340 to 350 | SSCSSCPLSKI |
| A23 | LMP2 | 131 to 139 | PYLFWLAAI |
| A24 | EBNA3A | 246 to 253 | LYSIFFDY |
| A24 | LMP2 | 419 to 427 | TYGPVFMCL |
| A24.02 | EBNA3B | 217 to 225 | TYSAGIVKI |
| A25 | LMP2 | 442 to 451 | VMSNTLLSAW |
| A29 | EBNA3A | 491 to 499 | VFSDGRVAC |
| A30.02 | EBNA3A | 176 to 184 | AYSSWMYSY |
| B7 | EBNA3A | 502 to 510 | GPAPAGPIV |
| B7 | EBNA3A | 379 to 387 | RPPIFIRRL |
| B7 | EBNA3C | 881 to 889 | QPRAPIRPI |
| B8 | EBNA3A | 158 to 166 | QAKWRLQTL |
| B8 | EBNA3A | 325 to 333 | FLRGRAYGL |
| B8 | BZLF1 | 190 to 197 | RAKFKQLL |
| B27.02 | EBNA3B | 244 to 254 | RRARSLSAERY |
| B27.02/.04/.05 | EBNA3C | 258 to 266 | RRIYDLIEL |
| B27.04 | LMP2 | 236 to 244 | RRRWRRLTV |
| B27.05 | EBNA3B | 149 to 157 | HRCQAIRKK |
| B27.05 | EBNA3C | 249 to 258 | LRGKWQRRYR |
| B27.05 | EBNA3C | 343 to 351 | FRKAQIQGL |
| B35 | EBNA3A | 458 to 466 | YPLHEQHGM |
| B35 | EBNA3B | 488 to 496 | AVLLHEESM |
| B35 | BZLF1 | EPLPQGQLTAY | |
| B35.01 | EBNA1 | 407 to 417 | HPVGEADYFEY |
| B39 | EBNA3C | 271 to 278 | HHIWQNLL |
| B44 | EBNA3B | 567 to 666 | VEITPYKPTW |
| B44.02 | EBNA3C | 281 to 290 | EENLLDFVRF |
| B44.02 | EBNA3C | 335 to 343 | KEHVIQNAF |
| B44.03 | EBNA3C | 163 to 171 | EGGVGWRHW |
| B60 | LMP2 | 200 to 208 | IEDPPFNSL |
| B62 | EBNA3A | 406 to 414 | LEKARGSTY |
| B62 | EBNA3B | 831 to 839 | GQGGSPTAM |
| B62 | EBNA3C | 213 to 222 | QNGALAINTF |